Science Corp.
Science Corp. is a clinical-stage neurotechnology company developing the Science Eye, a brain-computer interface retinal implant designed to restore functional vision for patients with degenerative eye diseases. Founded by Max Hodak, co-founder of Neuralink, the company combines AI-driven neural decoding with advanced bioelectronics to tackle one of the hardest problems in neural engineering.
Overview
Science Corporation is a clinical-stage medical technology company developing PRIMA, a brain-computer interface retinal implant designed to restore vision for patients with age-related macular degeneration, retinitis pigmentosa, and Stargardt disease. Founded by Max Hodak, the company also develops biohybrid neural interfaces and vessel perfusion technology. Science Corp. closed a $230 million Series C to fund commercialization of the PRIMA implant.
Funding History
Science Corp., Another Braintech Startup Founded By Neuralink Alums, Raises $230M Series C
Frequently Asked Questions
- How much has Science Corp. raised in total?
- Science Corp. has raised a total of $230M across 1 funding round.
- Who are Science Corp.'s investors?
- Science Corp.'s investors include Coatue Management.
- What does Science Corp. do?
- Science Corporation is a clinical-stage medical technology company developing PRIMA, a brain-computer interface retinal implant designed to restore vision for patients with age-related macular degeneration, retinitis pigmentosa, and Stargardt disease. Founded by Max Hodak, the company also develops biohybrid neural interfaces and vessel perfusion technology. Science Corp. closed a $230 million Series C to fund commercialization of the PRIMA implant.
- When was Science Corp. founded?
- Science Corp. was founded in 2021 and is headquartered in San Francisco, CA.
- Where is Science Corp. headquartered?
- Science Corp. is headquartered in San Francisco, CA.
Investors
Related Insights
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
The AI Healthcare sector is one of the most dynamic areas of AI investment in 2026. This report profiles the top-funded startups in the space, their investors, and the market dynamics driving growth.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.